Advocates Criticize Efforts to Roll Back Newborn Drug Testing

A debate is intensifying over the practice of drug testing pregnant women and newborns, with some activists asserting that the procedures are driven by racial bias and have disproportionately targeted minority mothers. These advocates, supported by organizations like the George Soros-funded Drug Policy Alliance, argue that such testing perpetuates harmful stereotypes and can lead to unnecessary family separations. However, critics contend that these arguments obscure the significant risks infants face when born exposed to drugs.

M Miriam Mack, senior legal counsel at the Movement for Family Power, stated in a webinar that drug testing is a tool to maintain a social hierarchy and "white supremacy." She also characterized the child-welfare system as a modern form of slavery, Indian boarding schools, and orphan trains, and invoked eugenics as a driving force behind reproductive policies. Other activists, such as Mishka Terplin of Doing Right by Birth, have highlighted instances of false positives from drug screenings, sometimes caused by common items like poppy-seed bagels or medical procedures, leading to the removal of newborns from their mothers' care.

Terplin referred to the "crack baby" panic as a "racist myth" and suggested that concerns about maternal drug use peaked in 2003, when federal law began requiring healthcare providers to report infants born with signs of prenatal drug exposure. This period, she noted, coincided with the opioid epidemic, which at the time primarily affected white families. An exposé from that year detailed numerous cases of infants dying from preventable causes after being sent home to families struggling with opioid addiction, with all the featured children being white.

Critics argue that the current narrative promoted by these activists downplays the dangers faced by substance-exposed infants. An estimated 500,000 substance-exposed infants are born annually in the U.S., and they face elevated risks of abuse, neglect, and death once discharged from the hospital. Organizations supporting the testing argue that focusing solely on racism ignores these critical safety concerns.

In recent years, advocacy has led to changes in reporting policies. Mass General Brigham Hospital in Boston has reportedly discouraged medical professionals from reporting mothers with positive drug tests to child-welfare agencies. In 2020, New York City’s Commission on Human Rights investigated whether hospitals were targeting minority mothers and newborns for drug testing, after which public hospitals made screenings voluntary. New Mexico enacted a law in 2019 that often resulted in mothers being sent home with substance-exposed newborns without mandatory intervention, relying instead on voluntary plans. In the subsequent two years, approximately one baby per month died from accidental poisonings, unsafe sleep, or neglect.

New Mexico Governor Michelle Lujan Grisham, who signed the 2019 law, has since expressed regret. "We were releasing, after they were well enough to go home, infants in the care of highly drug-addicted parents who were not required to take any service or get treatment for their addiction," she stated in February. "Now, I don’t know if there’s any better recipe for a disaster in America than that one." Mothers under the influence of drugs may face difficulties caring for an infant, and babies exposed to substances prenatally can experience significant health complications. The debate continues over how best to balance addressing potential maternal substance abuse with protecting the rights and well-being of both mothers and newborns.